Remote therapy to improve upper limb function in children with cerebral palsy
Development and Validation of a Remote Therapy Protocol Using Multimodal Sensor Fusion for Upper Limb Function Enhancement in Children With Cerebral Palsy
NA · Samsung Medical Center · NCT06272760
This study is testing a new home-based therapy program using sensors to help children with cerebral palsy improve their arm and hand skills.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 6 Years to 12 Years |
| Sex | All |
| Sponsor | Samsung Medical Center (other) |
| Locations | 1 site (Seoul) |
| Trial ID | NCT06272760 on ClinicalTrials.gov |
What this trial studies
This study focuses on developing and demonstrating a teletherapy protocol aimed at enhancing upper limb function in children diagnosed with cerebral palsy. It utilizes a home-based program that incorporates multimodal sensors for both evaluation and treatment of upper limb function. The intervention involves a hand-arm bimanual intensive training (Tele-HABIT) approach, allowing children to engage in therapy from home. The goal is to provide a convenient and effective method for improving motor skills in this population.
Who should consider this trial
Good fit: Ideal candidates for this study are children aged 6 to 12 years with cerebral palsy classified at MACS levels 1 to 4.
Not a fit: Patients with MACS level V, severe intellectual disabilities, or significant vision impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the upper limb functionality and overall quality of life for children with cerebral palsy.
How similar studies have performed: Other studies utilizing teletherapy and remote rehabilitation approaches have shown promising results, indicating potential success for this novel intervention.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 6 to 12 years * MACS level 1-4 * Diagnosed with CP due to central nervous system lesions Exclusion Criteria: * Individuals with a Manual Ability Classification System (MACS) level V, indicating an inability to use both hands in daily life activities. * Individuals who fall within levels 0 to 4 of the House Functional Classification System. * Individuals with severe intellectual disabilities, characterized by difficulties in understanding or following instructions. * Individuals with vision impairment that could affect participation in the therapy. * Individuals who have received a botulinum toxin injection in the upper extremity within the past 6 months.
Where this trial is running
Seoul
- Samsung Medical Center — Seoul, Korea, Republic of (RECRUITING)
Study contacts
- Principal investigator: JEONG-YI KWON, MD, PHD — Samsung Medical Center
- Study coordinator: JEONG-YI KWON, MD, PHD
- Email: jeongyi.kwon@samsung.com
- Phone: +821045911039
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cerebral Palsy, Cerebral palsy, Physical activity, Telerehabilitation, Accelerometer